Change Agents Corporation entered into a Business Loan and Security Agreement on July 24, 2026, obtaining a principal loan of $825,000 with net proceeds of $254,350 after fees and repayment of a prior $529,400 loan. The company issued a Confessed Judgment Secured Promissory Note repayable in 30 weekly installments of $37,125 beginning July 29, 2026, with a maturity date of March 3, 2027, and total repayment including interest of $1,188,000. Wholly-owned subsidiaries Avalon Healthcare System Inc., Avalon Laboratory Services, Inc., and Avalon Quantum AI LLC guaranteed the obligation. Additionally, the company issued 360,000 shares of common stock to the lender as consideration for a forbearance agreement related to the prior loan default. The filing includes customary restrictive covenants regarding debt, liens, and dividends. Change Agents Corporation operates in the healthcare services sector.

Avalon GloboCare Corp. rebranded as Change Agents Corporation effective July 20, 2026, and changed its Nasdaq ticker symbol to "CHGA" effective July 22, 2026. The company announced a strategic transformation into an agentic AI software company focusing on SaaS applications. Its current portfolio includes Beacon, an AI Generative Engine Optimization platform expected to launch in late Q3 2026, and Catch-Up, an autonomous AI-powered content creation platform currently in Phase 2 development. The company is also exploring AI opportunities in the defense and security sectors. The company operates in the software industry and develops agentic AI applications for businesses and content creators.

Avalon GloboCare Corp. entered into a securities purchase agreement with investor Allen O. Cage Jr. on June 30, 2026, for an aggregate price of $400,000.00. The transaction, which closed on July 2, 2026, involved the issuance of 400 shares of Series F Convertible Preferred Stock with a $1,000.00 stated value per share and 200,000 shares of common stock as additional consideration. The Series F Preferred Stock is convertible into common stock at $0.50 per share and is subject to mandatory redemption of 25% of outstanding shares quarterly from October 1, 2026, through January 1, 2027, at 125% of the stated value. Additionally, the company issued various stock options and restricted shares to consultants and officers. Avalon GloboCare Corp. is a healthcare services company.